Back to Search
LANE FAIRBAIRN, DO
DO
Family Medicine Physician
NPI: 1871649483IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
TL-1735(CO)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
45120(CO)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2005
Research & Publications (20)
Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.
PMID 19270262·Blood·2009
7-preclinical
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.
PMID 18559275·Eur J Pharmacol·2008
7-preclinical
Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist.
PMID 18644363·Eur J Pharmacol·2008
7-preclinical
The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine.
PMID 16075413·J Gene Med·2006
7-preclinical
Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI.
PMID 16539700·Virol J·2006
8-other
Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase.
PMID 16733832·J Gene Med·2006
7-preclinical
Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
PMID 16454648·Hum Gene Ther·2006
7-preclinical
Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase.
PMID 16506247·J Gene Med·2006
7-preclinical
Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo.
PMID 16397508·Gene Ther·2006
7-preclinical
Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro.
PMID 15496973·Leukemia·2005
8-other
Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
PMID 16435198·J Inherit Metab Dis·2005
8-other
Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers.
PMID 15247008·Ann N Y Acad Sci·2004
6-review
Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4.
PMID 15509504·Mol Ther·2004
7-preclinical
Genetic manipulation of drug sensitivity in haematopoietic cells.
PMID 15387894·Expert Rev Mol Med·2004
6-review
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.
PMID 15342932·Stem Cells·2004
8-other
Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.
PMID 15319033·Hum Gene Ther·2004
4-observational
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.
PMID 15251986·Blood·2004
8-other
Protection and selection for gene therapy in the hematopoietic system.
PMID 14978767·J Gene Med·2004
6-review
Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer.
PMID 12724138·Am J Physiol Cell Physiol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10350 E DAKOTA AVE
DENVER, CO 80247 - Phone
- (303) 338-4545
Quick Facts
- NPI
- 1871649483
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile